Search for content, post, videos

LIDDS’s Nanozolid registered in the US

Monica Wallter

LIDDS has announced that the United States Patent and Trademark Office has registered the trademark NanoZolid.

LIDDS thereby has exclusive rights to the trademark for products and services in the USA and in the EU, where NanoZolid has been registered since 2016.

“This is an essential, although expected, step in establishing the concept of LIDDS proprietary drug delivery technology NanoZolid for local depots and adds to our already strong IP portfolio,” confirms LIDDS CEO Monica Wallter.

Photo of Monica Wallter: LIDDS